Cidara Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -48.16M-55.73M-62.87M-41.50M-72.11M-42.47M-33.58M2.15M0.46M
Share-based Compensation 0.23M3.03M4.34M5.71M5.71M5.07M4.09M4.01M3.53M3.06M3.91M
Gains from Investment Securities 2.34M3.85M0.28M
Cash from Operations -7.71M-25.96M-39.77M-49.91M-56.70M-28.53M-54.41M-25.23M-28.47M-22.43M-176.53M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.04M0.18M0.03M-0.03M0.01M0.08M
Amortization of Deferred Charges 0.07M0.02M0.02M0.06M0.04M-1.71M0.76M-1.42M0.98M1.16M1.05M
Depreciation & Amortization (CF) 0.18M0.46M0.73M0.70M0.52M0.33M0.30M0.20M0.14M0.11M0.20M
Change in Working Capital
Change in Receivables -0.32M0.01M11.16M-5.82M0.48M10.41M-14.28M
Change in Inventory 6.10M-6.10M
Change in Accured Expenses 1.75M2.14M1.91M0.64M0.82M1.24M6.59M-1.09M-2.37M8.89M-1.00M
Investing Activities
Capital Expenditures 0.99M1.17M0.40M0.31M0.18M0.04M0.19M0.08M0.12M0.51M0.13M
Change in Acquisitions & Divestments 10.00M95.50M24.30M29.03M
Cash from Investing Activities -0.99M-46.09M25.48M4.47M14.30M-0.04M-0.19M-0.04M-0.12M-0.51M-0.13M
Financing Activities
Other financing activities 0.23M0.03M0.72M
Debt Issuance and Repayment
Long-Term Debt Issuances 0.93M
Long-Term Debt Repayments 2.96M4.44M2.59M
Short-Term Debt issuances 9.95M
Change in Capital Stock
Shares Issued 0.75M69.50M26.62M0.23M6.44M5.29M11.04M12.48M0.14M0.12M337.33M
Shares Repurchased 0.08M
Preferred Shares Issued 29.87M41.92M
Misc.
Cash from Financing Activities 31.31M111.81M37.09M20.88M56.15M14.27M37.28M44.60M-0.95M25.98M337.06M
Change in Cash 22.61M39.77M22.80M-24.55M13.75M-14.29M-17.32M19.32M-29.54M3.05M160.40M
Free Cash Flow -8.70M-27.13M-40.17M-50.22M-56.88M-28.57M-54.60M-25.31M-28.59M-22.94M-176.66M
Net Cash Flow 22.61M39.77M22.80M-24.55M13.75M-14.29M-17.32M19.32M-29.54M3.05M160.40M